What Is the N-Telopeptide Urine Normal Range?

The normal range for urinary N-telopeptide (NTx) in healthy premenopausal women and men over 30 is roughly 3 to 63 nmol BCE per mmol creatinine, while younger men (ages 21 to 30) can range from about 4 to 92 nmol BCE/mmol creatinine. Those numbers, however, tell only part of the story. NTx values shift with the time of day you collect the sample, your age, your kidney function, whether you recently ate, and even whether you have been physically active or stuck in bed. Understanding what a “normal” result actually means requires knowing how easily these values move and what your doctor is looking for when they order the test.

What NTx Measures and Why It Matters

Your bones are not static. They are constantly being broken down by cells called osteoclasts and rebuilt by cells called osteoblasts. When osteoclasts chew through bone, they release fragments of type I collagen, the protein scaffold that gives bone its structure. One of those fragments is the N-telopeptide, or NTx. Because NTx is a stable end product of that breakdown process and does not need further processing by the liver or kidneys to be generated, it provides a fairly direct snapshot of how fast bone is being resorbed at any given time.¹

When results come back elevated, it signals that bone is being broken down faster than expected. When values fall after starting medication, it suggests the drug is doing its job. That dual role as both a diagnostic clue and a treatment monitor is why NTx urine tests remain common in clinical practice, even as blood-based alternatives gain ground.

Published Reference Ranges by Age and Sex

Most labs report urinary NTx as nanomoles of bone collagen equivalents (BCE) per millimole of creatinine. The creatinine correction accounts for how concentrated or dilute the urine sample is. In a study of healthy men, the reference range for those aged 21 to 30 was 4 to 92 nmol BCE/mmol creatinine. For men over 30, the range tightened to 3 to 63, which was essentially the same as the range previously established for premenopausal women.² After menopause, women commonly see NTx values climb because declining estrogen accelerates bone resorption.

To illustrate how much pathology can push the numbers, one study comparing people with osteopenia or osteoporosis to healthy controls found a mean urinary NTx of about 183 in the osteoporosis group versus about 50 in controls, with enormous individual spread in the disease group.¹ So while the “normal” ceiling sits somewhere in the 60s for most adults, people with active bone loss can easily double or triple that number.

Why Time of Day Changes Your Result

One of the biggest practical pitfalls with urinary NTx is that the result depends heavily on when you collect the sample. The NTx-to-creatinine ratio follows a significant circadian rhythm: it peaks in the early morning hours, then drops through the day to a low point in the early evening. In one study, the early-morning ratio sat at about 122% of the 24-hour mean, meaning it was more than a fifth higher than what you would get from a late-afternoon sample.³ The researchers found that the rhythm was driven mainly by fluctuations in creatinine excretion rather than NTx excretion itself, but the practical upshot is the same: comparing a morning sample with an afternoon sample is comparing apples with oranges.

Standard kits instruct patients to collect a second-morning void, but the allowable window (roughly 6:00 to 8:30 a.m.) falls right during the period when NTx excretion is swinging from its overnight peak toward a rapid daytime decline. Some researchers have proposed tightening collection to a fixed two-hour morning window, from 6:00 to 8:00 a.m. after an overnight fast, to reduce that noise.⁴ If your doctor tracks your NTx over time, collecting at roughly the same hour each visit matters far more than most patients realize.

How Much Natural Fluctuation to Expect

Even when you control for collection time, urinary NTx bounces around from day to day. In postmenopausal women studied repeatedly, the short-term coefficient of variation (a measure of scatter) was about 13% for urine NTx, compared with only about 6% for the same marker measured in blood. Over a longer timeframe the gap widened further, with urine NTx showing roughly 16% variation versus about 8% for serum.⁵ That means a single urine NTx reading that looks a little high or low may simply reflect normal biological noise rather than a meaningful change in bone health.

This variability has a direct clinical consequence. For a doctor to be 90% confident that a drop in urine NTx after starting a bone-protecting drug reflects a real treatment effect and not random fluctuation, the value needs to fall by at least about 31%.⁵ A separate analysis of serial serum NTx measurements arrived at a broadly similar threshold, finding that a critical difference of about 34% between two successive values was needed before you could attribute the change to biology rather than measurement noise.⁶ Small shifts of 10 or 15 percent, in other words, are usually not worth worrying about.

Using NTx to Track Osteoporosis Treatment

The most common clinical reason for ordering a urine NTx test is to check whether a bisphosphonate or other bone-protective medication is working. Bisphosphonates slow bone resorption, so NTx should drop noticeably within a few months of starting treatment. In a clinical practice evaluation, decreases in urine NTx correlated with gains in spine bone density over time. Patients who showed a weaker NTx response were more likely to have either secondary causes of bone loss (like vitamin D deficiency, thyroid problems, or steroid use) or poor medication compliance.⁷

Another study estimated that about 78% of patients on bisphosphonates showed a meaningful urine NTx response, compared with about 67% for those on hormone replacement therapy.⁸ The fact that not everyone responds is part of why these tests exist: catching a non-responder early lets the clinician investigate potential underlying causes rather than waiting years for a bone density scan to reveal the problem.

NTx and Fracture Risk

High NTx levels do not just flag fast bone turnover in the abstract; they connect to real-world fracture risk. In the OFELY study, a large prospective study of postmenopausal women, those with urinary NTx values in the highest quartile had roughly 1.7 times the fracture risk of women with lower values. Other resorption markers in the same cohort showed similar patterns, with risk ratios ranging from about 1.7 to 2.3 depending on the marker. Crucially, these associations held even after adjusting for bone mineral density, meaning the turnover rate added fracture-prediction information on top of what a DEXA scan alone could provide.⁹

When NTx Is Used in Cancer Care

Beyond osteoporosis, urinary NTx has a meaningful role in oncology, particularly for patients whose cancer has spread to bone. In people with metastatic bone disease, baseline NTx values of 100 nmol/mmol creatinine or higher (well above the normal range) marked dramatically elevated risk: those patients were roughly 19 times more likely to suffer a skeletal complication or die within three months compared with patients whose NTx was below 100.¹⁰ In multivariate models, NTx outperformed several other clinical variables for predicting who would have the worst skeletal outcomes.

For breast cancer patients with bone metastases specifically, the change in NTx at three months after starting treatment was strongly tied to survival.¹¹ In this context, a “normal” NTx is less about fitting within a reference range and more about trending downward in response to bone-targeted therapy.

Children and Adolescents Have Much Higher Values

If you are looking at a child’s NTx result and comparing it to the adult reference range, you will get a misleading picture. Growing skeletons are remodeling at a far higher rate, so NTx values in prepubertal children run four to five times higher than in adults.¹² Levels generally decrease with age during childhood, with a bump around early puberty, and then gradually settle toward adult ranges by late adolescence. In boys, the decline is fairly steady. In girls, there can be a temporary rise around ages 9 to 10 before continuing downward.¹³ Puberty stage, not calendar age alone, drives these shifts.

In conditions like osteogenesis imperfecta, a genetic disorder that weakens bone, NTx values in children and adolescents are typically elevated even above the already-high pediatric norms. One study found that 44 out of 52 young patients with the condition had NTx levels above the 75th percentile for age-matched healthy children.¹⁴

Factors That Can Falsely Raise or Lower Your Result

Several things beyond bone disease can push urinary NTx outside its expected range:

• Bed rest: Even a single day of immobility is enough to trigger a measurable rise. In one controlled trial of healthy subjects, NTx excretion jumped by about 29% after just two days of bed rest.¹⁵ This remained elevated in both younger and older men throughout 14 days of bed rest.¹⁶
• Recent fracture: A healing fracture drives up resorption markers. After vertebral fracture, urinary NTx peaked at about three weeks and stayed significantly elevated for roughly eight weeks.¹⁷
• Calcium intake: Drinking calcium-fortified water suppressed serum NTx by about 25% within six to nine hours, and even plain low-calcium water produced a modest dip of about 11%.¹⁸ That is why fasting samples are preferred.
• Paget’s disease and other high-turnover conditions: Disorders like Paget’s disease, hyperparathyroidism, and hyperthyroidism all push collagen degradation markers well above normal, often by several standard deviations.¹⁹ NTx is considered among the most sensitive markers for managing Paget’s specifically.²⁰

Any of these situations can make a single NTx result uninterpretable without clinical context. If you have been hospitalized, recently broken a bone, or had a calcium-rich meal before your sample, mention it to your clinician.

Kidney Disease Complicates Interpretation

Urinary NTx is corrected for creatinine, which works well enough in people with normal kidneys. In chronic kidney disease, though, the picture gets muddier. As kidney function declines, serum NTx concentrations tend to rise partly because of impaired urinary excretion and partly because kidney disease itself disturbs bone metabolism.²¹ The creatinine correction in urine may also become unreliable when creatinine clearance is abnormal. For these patients, serum-based markers tend to be preferred, and interpreting any urinary bone marker needs to be done alongside kidney function data.²²

Urine Versus Blood NTx Testing

NTx can be measured in both urine and serum, and the two versions track each other reasonably well. In postmenopausal women, serum and urine NTx assays both distinguished between those on hormone therapy and those not, showing a 35 to 40% difference between treated and untreated groups.²³ However, serum NTx tends to show lower day-to-day variability, and serum markers in general did a better job distinguishing healthy people from those with osteoporosis or other metabolic bone diseases in at least one head-to-head comparison.²⁴

Blood tests also sidestep the collection-timing headache: a fasting blood draw is simpler to standardize than a timed urine void, and creatinine correction is not needed. The trade-off is that urine NTx has a longer track record in clinical trials, and many established treatment-response thresholds were originally defined using urine values. Both remain in active clinical use.

Lab Method Can Shift the Numbers

Not all NTx assays are created equal. In a multi-lab reproducibility study, the Vitros ECi automated assay showed far tighter results than the older Osteomark manual assay, with average run-to-run variation of about 7% versus 30%.²⁵ That is an enormous difference in precision. A newer lateral-flow immunoassay designed for point-of-care settings showed high correlation with standard ELISA methods, though its clinical adoption is still limited.²⁶ Older comparisons also noted that reference ranges could shift depending on whether the assay measured free crosslinks or peptide-bound fragments.²⁷

The practical lesson is straightforward: if you are tracking NTx over time, try to use the same lab running the same assay for every sample. Switching labs mid-stream can introduce variation that has nothing to do with your bones. And if your report includes a lab-specific reference range printed alongside your result, use that range rather than a generic number you found online, because the cutoffs were calibrated for that particular assay platform.